{{위키데이터 속성 추적}}
{{전문가 필요|생물학}}
{{Chembox
<!-- Images -->
| ImageFile = Dehydroepiandrosteron.svg
| ImageSize = 225px
| ImageAlt = 
| ImageFile1 = Dehydroepiandrosterone molecule ball.png
| ImageSize1 = 235px
| ImageAlt1 = 
<!-- Names -->
| IUPACName = 3β-Hydroxyandrost-5-en-17-one
| SystematicName = (3''S'',8''R'',9''S'',10''R'',13''S'',14''S'')-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[''a'']phenanthren-17-one
| OtherNames = Androstenolone; Prasterone; Androst-5-en-3β-ol-17-one; 5,6-Didehydroepiandrosterone;<ref name="Devillers2009">{{서적 인용| first = James | last = Devillers | name-list-format = vanc |title=Endocrine Disruption Modeling|url=https://books.google.com/books?id=bWHMBQAAQBAJ&pg=PA339|date=27 April 2009|publisher=CRC Press|isbn=978-1-4200-7636-3|pages=339–}}</ref> Dehydroisoepiandrosterone
| Watchedfields = changed
| verifiedrevid = 443682301
<!-- Sections -->
| Section1 = {{Chembox Identifiers
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 53-43-0
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 28689
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 90593
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5670
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01708
| PubChem = 5881
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FMGSKLZLMKYGDP-USOAJAOKSA-N
| SMILES = O=C3[C@]2(CC[C@@H]1[C@@]4(C(=C/C[C@H]1[C@@H]2CC3)\C[C@@H](O)CC4)C)C
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 459AG36T1B
  }}
| Section2 = {{Chembox Properties
| C=19 | H=28 | O=2
| MolarMass = 288.424 g/mol
| Appearance = 
| Density = 
| MeltingPt = 148.5
| BoilingPt = 
| Solubility = 
  }}
| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
| Section6 = {{Chembox Pharmacology
| ATCvet = yes
| ATCCode_prefix = A14
| ATCCode_suffix = AA07
| ATC_Supplemental = <br />{{ATC|G03|EA03}} (combination with [[에스트로겐]])
| AdminRoutes = [[:en:Oral administration|By mouth]], [[:en:vaginal administration|vaginal]] ([[좌약|insert]]), [[근육 주사]] (as [[prasterone enanthate]]), [[주사 (의학)|injection]] (as [[prasterone sodium sulfate]])
| Bioavail = 50%<ref name="CuppTracy2002">{{서적 인용| first1 = Melanie Johns | last1 = Cupp | first2 = Timothy S. | last2 = Tracy | name-list-format = vanc | title=Dietary Supplements: Toxicology and Clinical Pharmacology|url=https://books.google.com/books?id=vuqPBAAAQBAJ&pg=PA135|date=10 December 2002|publisher=Springer Science & Business Media|isbn=978-1-59259-303-3|pages=135–}}</ref>
| Excretion = [[오줌]]
| HalfLife = {{abbr|DHEA|Dehydroepiandrosterone}}: 25&nbsp;minutes<ref name="OddensVermeulen1996">{{서적 인용| vauthors = Oddens BJ, Vermeulen A | title=Androgens and the Aging Male|url=https://books.google.com/books?id=efEnI1VdmtsC&pg=PA5|date=15 November 1996|publisher=CRC Press|isbn=978-1-85070-763-9|pages=5–}}</ref><br />{{abbr|DHEA-S|Dehydroepiandrosterone sulfate}}: 11&nbsp;hours<ref name="OddensVermeulen1996" />
| Metabolism = [[간|Hepatic]]<ref name="CuppTracy2002" />
| ProteinBound = 
  }}
}}
'''디하이드로에피안드로스테론'''({{llang|en|dehydroepiandrosterone}}, '''DHEA''')는 [[부신]], [[생식샘]], [[뇌]]에서 분비되는 [[스테로이드 호르몬]]이다. DHEA는 부신과 다른 [[조직 (생물학)|조직]]에 있는 [[안드로겐]]과 [[에스트로겐]] [[성호르몬]]의 [[생합성]]에세 [[대사 중간생성물]]으로 기능한다. 하지만 DHEA는 다양한 잠재적 생물학적 효과를 가지고 있는데, [[핵 수용체]]와 [[세포 표면 수용체]] 배열을 결속시키거나 [[신경 스테로이드]]와 [[뉴로트로핀 수용체]]의 조절체(modulator)로 역할한다.

== 각주 ==
{{각주}}

== 외부 링크 ==
* {{위키공용분류-줄}}

{{호르몬}}
{{스테로이드 호르몬}}

{{토막글|생물학}}

[[분류:안드로겐과 단백동화 스테로이드]]
[[분류:에스트로겐]]
[[분류:성호르몬]]
[[분류:안드로스탄]]
[[분류:NMDA 수용체 작용제]]
[[분류:뉴로스테로이드]]
[[분류:페로몬]]
[[분류:프레그난 X 수용체 작용제]]
[[분류:시상하부-뇌하수체-생식샘 축 호르몬]]